Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas H Jacobs

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
BMC Geriatrics|August 30, 2022
Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicityImke Ortland, Monique Mendel Ott, Michael Kowar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2006
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomasNorbert Galldiks, Lutz W Kracht, Lothar Burghaus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2021
Imaging of the glioma microenvironment by TSPO PETBastian Zinnhardt, Federico Roncaroli, Claudia Foray, et al.
Molecular Imaging|October 23, 2012
Volumetry of [¹¹C]-methionine positron emission tomographic uptake as a prognostic marker before treatment of patients with malignant gliomaNorbert Galldiks, Veronika Dunkl, Lutz W Kracht, et al.
Molecular Imaging|March 30, 2011
Imaging herpes simplex virus type 1 amplicon vector-mediated gene expression in human glioma spheroidsChristine Kaestle, Alexandra Winkeler, Raphaela Richter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2013
Optimizing glioblastoma temozolomide chemotherapy employing lentiviral-based anti-MGMT shRNA technologyThomas Viel, Parisa Monfared, Sonja Schelhaas, et al.
Neuro-Oncology|June 22, 2013
Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et alMarkus Hutterer, Martha Nowosielski, Daniel Putzer, et al.
Atherosclerosis|April 8, 2014
Serial F-18-FDG PET/CT distinguishes inflamed from stable plaque phenotypes in shear-stress induced murine atherosclerosisChristian Wenning, Christopher Kloth, Michael T Kuhlmann, et al.
Molecular Imaging and Biology|November 10, 2021
Voxel-Based Analysis of the Relation of 3'-Deoxy-3'-[<sup>18</sup>F]fluorothymidine ([<sup>18</sup>F]FLT) PET and Diffusion-Weighted (DW) MR Signals in Subcutaneous Tumor Xenografts Does Not Reveal a Direct Spatial Relation of These Two ParametersSonja Schelhaas, Lynn Johann Frohwein, Lydia Wachsmuth, et al.
Plos One|April 25, 2014
An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomasMartha Nowosielski, Matthew D DiFranco, Daniel Putzer, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
BMC Geriatrics|August 30, 2022
Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicityImke Ortland, Monique Mendel Ott, Michael Kowar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2006
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomasNorbert Galldiks, Lutz W Kracht, Lothar Burghaus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2021
Imaging of the glioma microenvironment by TSPO PETBastian Zinnhardt, Federico Roncaroli, Claudia Foray, et al.
Molecular Imaging|October 23, 2012
Volumetry of [¹¹C]-methionine positron emission tomographic uptake as a prognostic marker before treatment of patients with malignant gliomaNorbert Galldiks, Veronika Dunkl, Lutz W Kracht, et al.
Molecular Imaging|March 30, 2011
Imaging herpes simplex virus type 1 amplicon vector-mediated gene expression in human glioma spheroidsChristine Kaestle, Alexandra Winkeler, Raphaela Richter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2013
Optimizing glioblastoma temozolomide chemotherapy employing lentiviral-based anti-MGMT shRNA technologyThomas Viel, Parisa Monfared, Sonja Schelhaas, et al.
Neuro-Oncology|June 22, 2013
Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et alMarkus Hutterer, Martha Nowosielski, Daniel Putzer, et al.
Atherosclerosis|April 8, 2014
Serial F-18-FDG PET/CT distinguishes inflamed from stable plaque phenotypes in shear-stress induced murine atherosclerosisChristian Wenning, Christopher Kloth, Michael T Kuhlmann, et al.
Molecular Imaging and Biology|November 10, 2021
Voxel-Based Analysis of the Relation of 3'-Deoxy-3'-[<sup>18</sup>F]fluorothymidine ([<sup>18</sup>F]FLT) PET and Diffusion-Weighted (DW) MR Signals in Subcutaneous Tumor Xenografts Does Not Reveal a Direct Spatial Relation of These Two ParametersSonja Schelhaas, Lynn Johann Frohwein, Lydia Wachsmuth, et al.
Plos One|April 25, 2014
An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomasMartha Nowosielski, Matthew D DiFranco, Daniel Putzer, et al.
Pageof 15